Wei Zhou, PhD
Dr. Wei Zhou is currently a postdoctoral fellow in the laboratory of Dr. Rugang Zhang at The Wistar Institute in Philadelphia. He earned his Ph.D. degree from Nankai University in Tianjin, China. As a graduate student, he focused on the metastasis and recurrence of ovarian cancer. He was awarded by the Roche Diagnostics Scholarship in 2015. To further pursue his interests in epigenetic regulation of ovarian cancer and exploring the novel therapeutic approaches, Dr. Zhou joined Dr. Rugang Zhang’s lab in 2019. His current research focuses on developing novel personalized therapeutic strategies by targeting ARID1A-mutated ovarian cancers. In particular, Dr. Zhou is interested in the mechanism of dysregulation of the mevalonate pathway. In addition, he is also interested in the effect of cholesterol-lowering drugs in ARID1A-mutated ovarian cancers. The ultimate goal of Dr. Zhou’s research is to develop the first effective therapy targeting ARID1A-mutated ovarian cancer and improve the prognosis of ovarian cancer patients.